openPR Logo
Press release

Intravenous Access Devices Market - A Market Worth Observing Growth | Hospira, Inc., Becton, Dickinson and Company, CareFusion Corp.

08-21-2020 09:42 AM CET | Health & Medicine

Press release from: Transparency Market Research

Intravenous Access Devices Market - A Market Worth Observing

A new Transparency Market Research report states that the global intravenous access devices market stood at US$27.2 bn in 2012 and is predicted to reach US$46.5 bn by 2019. It is predicted to expand at a CAGR of 7.80% from 2013 to 2019. The title of the report is “Intravenous Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

Read Report Overview - https://www.transparencymarketresearch.com/intravenous-access-devices.html

As per the report, the increasing occurrence of targeted diseases such as viral infections and cancers and technological developments in products are amongst the chief factors stimulating the market for intravenous access devices. In addition, factors such as the rising global aging population and rising advancements in vaccines will further augment the growth of the market for intravenous access devices.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1723

Furthermore, the increasing disposable incomes of consumers in developing countries and the increasing patient pool have emerged as key opportunities in the market. On the other hand, factors such as the absence of regulatory approvals for intravenous insulin infusion pumps within the key markets such as the U.S. market may impede the growth of the overall market. In addition, the risks involved in the usage of needles may also have a negative impact on the growth of the market.

On the basis of product type, the market is segmented into intravenous catheters, intravenous needles, and intravenous infusion pumps. Amongst these, the segment of intravenous catheters is further segmented into midline peripheral catheters and central catheters. The segment of intravenous infusion pumps is further segmented into insulin fusion pumps, patient controlled analgesia (PCA) infusion pumps, parenteral feeding infusion pumps, and syringe infusion pumps.

Request for Analysis of COVID-19 Impact on Intravenous Access Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1723

Amongst these, in 2012, on the basis of revenue, intravenous catheters held the largest share in the market and is predicted to expand at the greatest CAGR in the forecast horizon. This is due to their extensive utilization along with a number of other access devices such as needles and infusion pumps. In addition, the economical prices of intravenous catheters as compared to infusion pumps will further augment their demand.

In terms of geography, the report segments the market into North America, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Rest of the World (RoW). Amongst these, North America held the largest share in the market on the basis of revenue in 2012 due to the growing aging population and the increasing prevalence of viral infections and cancers. On the other hand, Asia Pacific is predicted to exhibit the greatest CAGR of 9.40% between 2013 and 2019. This is due to the improved healthcare infrastructure and the rising healthcare expenditure in this region.

Buy Intravenous Access Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1723<ype=S

As stated in the report, the prominent players dominant in the market are Becton, Dickinson and Company, Hospira, Inc., CareFusion Corporation, B. Braun Melsungen AG, Smiths Medical, and Baxter International, among others.

More Trending Reports by Transparency Market Research –

High Throughput Process Development Market: https://www.biospace.com/article/high-throughput-process-development-market-demand-for-consumables-and-reagents-to-remain-strong/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Access Devices Market - A Market Worth Observing Growth | Hospira, Inc., Becton, Dickinson and Company, CareFusion Corp. here

News-ID: 2118324 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Intravenous

Rising Cancer Prevalence Driving The Intravenous Solutions Market: Critical Driv …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Intravenous Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for intravenous solutions has experienced robust expansion recently and is projected to increase from $14 billion in 2024 to $14.91 billion in 2025, reflecting a compound annual growth rate of 6.5%; this upward
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market Soliris Intravenous Market Overview: The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031 Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USD
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075 Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness